Abstract:Tinnitus is one of the three classical symptoms of Ménière’s disease (MD), an inner ear disease that is often accompanied by endolymphatic hydrops. Previous studies indicate that tinnitus in MD patients is dominated by low frequencies, whereas tinnitus in non-hydropic pathologies is typically higher in frequency. Tinnitus of rather low-frequency (LF) quality was also reported to occur for about 90 s in normal-hearing participants after presentation of intense, LF sound (120 dB SPL, 30 Hz, 90 s). LF sound has b… Show more
“…Meniere disease (MD) is a rare inner ear disorder with a significant genetic contribution [4] , characterized by episodes of vertigo, tinnitus and sensorineural hearing loss [5] . Although vertigo attacks are considered as the main symptom in the first years of the disease, persistent tinnitus is described as the most troublesome symptom by many MD patients [ 6 , 7 ].…”
Background
tinnitus is a heterogeneous condition associated with audiological and/or mental disorders. Chronic, severe tinnitus is reported in 1% of the population and it shows a relevant heritability, according to twins, adoptees and familial aggregation studies. The genetic contribution to severe tinnitus is unknown since large genomic studies include individuals with self-reported tinnitus and large heterogeneity in the phenotype. The aim of this study was to identify genes for severe tinnitus in patients with extreme phenotype.
Methods
for this extreme phenotype study, we used three different cohorts with European ancestry (Spanish with Meniere disease (MD), Swedes tinnitus and European generalized epilepsy). In addition, four independent control datasets were also used for comparisons. Whole-exome sequencing was performed for the MD and epilepsy cohorts and whole-genome sequencing was carried out in Swedes with tinnitus.
Findings
we found an enrichment of rare missense variants in 24 synaptic genes in a Spanish cohort, the most significant being
PRUNE2, AKAP9, SORBS1, ITGAX, ANK2, KIF20B
and
TSC2
(
p
< 2E
−04
), when they were compared with reference datasets. This burden was replicated for
ANK2
gene in a Swedish cohort with 97 tinnitus individuals, and in a subset of 34 Swedish patients with severe tinnitus for
ANK2, AKAP9
and
TSC2
genes (
p
< 2E
−02
). However, these associations were not significant in a third cohort of 701 generalized epilepsy individuals without tinnitus. Gene ontology (GO) and gene-set enrichment analyses revealed several pathways and biological processes involved in severe tinnitus, including membrane trafficking and cytoskeletal protein binding in neurons.
Interpretation
a burden of rare variants in
ANK2, AKAP9
and
TSC2
is associated with severe tinnitus
. ANK2,
encodes a cytoskeleton scaffolding protein that coordinates the assembly of several proteins, drives axonal branching and influences connectivity in neurons.
“…Meniere disease (MD) is a rare inner ear disorder with a significant genetic contribution [4] , characterized by episodes of vertigo, tinnitus and sensorineural hearing loss [5] . Although vertigo attacks are considered as the main symptom in the first years of the disease, persistent tinnitus is described as the most troublesome symptom by many MD patients [ 6 , 7 ].…”
Background
tinnitus is a heterogeneous condition associated with audiological and/or mental disorders. Chronic, severe tinnitus is reported in 1% of the population and it shows a relevant heritability, according to twins, adoptees and familial aggregation studies. The genetic contribution to severe tinnitus is unknown since large genomic studies include individuals with self-reported tinnitus and large heterogeneity in the phenotype. The aim of this study was to identify genes for severe tinnitus in patients with extreme phenotype.
Methods
for this extreme phenotype study, we used three different cohorts with European ancestry (Spanish with Meniere disease (MD), Swedes tinnitus and European generalized epilepsy). In addition, four independent control datasets were also used for comparisons. Whole-exome sequencing was performed for the MD and epilepsy cohorts and whole-genome sequencing was carried out in Swedes with tinnitus.
Findings
we found an enrichment of rare missense variants in 24 synaptic genes in a Spanish cohort, the most significant being
PRUNE2, AKAP9, SORBS1, ITGAX, ANK2, KIF20B
and
TSC2
(
p
< 2E
−04
), when they were compared with reference datasets. This burden was replicated for
ANK2
gene in a Swedish cohort with 97 tinnitus individuals, and in a subset of 34 Swedish patients with severe tinnitus for
ANK2, AKAP9
and
TSC2
genes (
p
< 2E
−02
). However, these associations were not significant in a third cohort of 701 generalized epilepsy individuals without tinnitus. Gene ontology (GO) and gene-set enrichment analyses revealed several pathways and biological processes involved in severe tinnitus, including membrane trafficking and cytoskeletal protein binding in neurons.
Interpretation
a burden of rare variants in
ANK2, AKAP9
and
TSC2
is associated with severe tinnitus
. ANK2,
encodes a cytoskeleton scaffolding protein that coordinates the assembly of several proteins, drives axonal branching and influences connectivity in neurons.
“…Interestingly, 80% of individuals with severe tinnitus also suffer from hyperacusis [39], but the molecular links between severe tinnitus and hyperacusis have not been established. While vertigo attacks are noted as the primary symptom during the initial years in individuals suffering from MD, severe tinnitus is reported as the most troublesome symptom by many patients when episodes of vertigo are scarce over time [40,41].…”
Meniere disease (MD) is a debilitating disorder of the inner ear defined by sensorineural hearing loss (SNHL) associated with episodes of vertigo and tinnitus. Severe tinnitus, which occurs in around 1% of patients, is a multiallelic disorder associated with a burden of rare missense single nucleotide variants in synaptic genes. Rare structural variants (SVs) may also contribute to MD and severe tinnitus. In this study, we analyzed exome sequencing data from 310 MD Spanish patients and selected 75 patients with severe tinnitus based on a Tinnitus Handicap Inventory (THI) score > 68. Three rare deletions were identified in two unrelated individuals overlapping the ERBB3 gene in the positions: NC_000012.12:g.56100028_56100172del, NC_000012.12:g.56100243_56101058del, and NC_000012.12:g.56101359_56101526del. Moreover, an ultra-rare large duplication was found covering the AP4M1, COPS6, MCM7, TAF6, MIR106B, MIR25, and MIR93 genes in another two patients in the NC_000007.14:g.100089053_100112257dup region. All the coding genes exhibited expression in brain and inner ear tissues. These results confirm the contribution of large SVs to severe tinnitus in MD and pinpoint new candidate genes to get a better molecular understanding of the disease.
“…Hearing may improve between episodes, but as the disease progresses, permanent losses are apparent leading to inverted V audiogram. Almost 50% patients totally lose their hearing in the affected ear fourteen years following their diagnosis (8) . According to the severity of hearing loss between attacks, there are four stages of hearing loss in MD (500 HZ-4 KHZ average): stage one ≤ 25 dB HL), stage two (26-40 dB HL), stage three (41-70 dB HL), and stage four (>71 dB HL) (9) .…”
Section: B) Hearing Lossmentioning
confidence: 99%
“…Tinnitus worsens over time and becomes chronic, even when there are no attacks, with the progression of the disease. It described as "roaring" or "ringing" and corresponds to hearing loss (8) .…”
Background: Meniere's disease (MD) is a peripheral vestibular disorder presented presented with fluctuating aural symptoms (fullness, tinnitus and hearing loss). In addition to recurrent spontaneous vertigo lasting between few minutes to several hours. Based on these symptoms, there are two categories of MD: definite and probable. Objective: The objective of this review article is to present an overview about recent methods for diagnosis of MD. Methods: We looked for data on Meniere's disease, Tinnitus, Vertigo, and Electrocochleography in medical journals and databases like PubMed, Google Scholar, and Science Direct. However, only the most recent or extensive study was taken into account between February 2015 and January 2023. References from related works were also evaluated by the authors. There are not enough resources to translate documents into languages other than English, hence those documents have been ignored. It was generally agreed that documents such as unpublished manuscripts, oral presentations, conference abstracts, and dissertations did not qualify as legitimate scientific study. Conclusion: MD is diagnosed clinically since it typically manifests as unilateral ear problems that might remain for decades. Attacks from MD are sporadic and episodic, with remissions in between. As there is no definitive vestibular testing for MD, these tests are typically carried out to rule out disorders with similar symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.